首页> 美国卫生研究院文献>Medical Science Monitor : International Medical Journal of Experimental and Clinical Research >Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients

【2h】

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients

机译：基于4个因素的纤维化指数（FIB-4）预测慢性丙型肝炎病毒（HCV）患者的肝硬化和肝细胞癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAlthough both hepatic fibrosis progression and hepatitis C virus (HCV) contribute to hepatocellular carcinoma (HCC) development, early detection of HCC remains challenging. Therefore, we evaluated clinical markers of fibrosis in HCV patients to improve early HCC diagnosis.

机译：背景技术尽管肝纤维化进展和丙型肝炎病毒（HCV）都有助于肝细胞癌（HCC）的发展，但早期检测HCC仍然具有挑战性。因此，我们评估了HCV患者纤维化的临床标志物，以改善HCC的早期诊断。

著录项

期刊名称 Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
作者
Xu Li; Hongqin Xu; Pujun Gao;
展开▼
作者单位

展开▼
年(卷),期 2019(25),-1
年度 2019
页码 7243–7250
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
Carcinoma Hepatocellular; Hepatitis C; Liver Cirrhosis;

机译：肝细胞癌;丙型肝炎;肝硬化;

相似文献

外文文献
中文文献
专利

1. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co‐infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End‐Stage Liver Disease as Compared to HCV Mono‐infected Patients [J] . Salmon‐Ceron Dominique, Nahon Pierre, Layese Richard, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2019 ,第3期

机译：与HCV单声道患者相比，人类免疫缺陷病毒/丙型肝炎病毒（HCV）有关肝硬化患者的肝硬化患者不再处于肝细胞癌或末期肝病的风险较高
2. High Liver Fibrosis Index FIB-4 Is Highly Predictive of Hepatocellular Carcinoma in Chronic Hepatitis B Carriers [J] . Suh Beomseok, Park Sehhoon, Shin Dong Wook, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2015 ,第4期

机译：高肝纤维化指数FIB-4可以高度预测慢性乙型肝炎携带者中的肝细胞癌
3. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma [J] . Xiao Guangqin, Zhu Feng, Wang Min, Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver . 2016 ,第10期

机译：APRI和FIB-4预测与乙肝病毒相关的肝纤维化并发肝细胞癌的诊断准确性
4. Comparison of APRI, FIB-4 and fibro test in prediction of fibrosis and cirrhosis in patients with hepatitis C [C] . Iram Zubair, Bilal Wajid International Bhurban Conference on Applied Sciences and Technology . 2018

机译：APRI，FIB-4和纤维蛋白检测在丙型肝炎患者纤维化和肝硬化预测中的比较
5. An exploratory study for the discovery of non-invasive hepatocellular carcinoma biomarkers among high-risk hepatitis C virus infected patients. [D] . Abdalla, Moemen. 2009

机译：在高危丙型肝炎病毒感染患者中发现非侵入性肝细胞癌生物标志物的探索性研究。
6. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study [O] . Roberto Catanzaro, Alice Aleo, Morena Sciuto, 2021

机译：FIB-4和APRI评分预测慢性乙型肝炎患者严重肝纤维化：一项单眼回顾研究
7. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients [O] . Xu Li, Hongqin Xu, Pujun Gao 2019

机译：基于4因素（FIB-4）的纤维化指数预测肝硬化和慢性丙型肝炎病毒（HCV）患者的肝细胞癌

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients

摘要

著录项

相似文献

相关主题

期刊订阅